PharVision Advisers »

Exponent shares owned by PharVision Advisers

Quarter-by-quarter ownership of Exponent (EXPO) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Exponent

Tip: Access up to 7 years of quarterly data

All positions including Exponent held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exponent by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $226k 2.5k 89.10

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Exponent

BlackRock
Vanguard Group
Kayne Anderson Rudnick Investment Management
Conestoga Capital Advisors
Geneva Capital Management
State Street Corporation
Geode Capital Management
Neuberger Berman Group
Dimensional Fund Advisors
Northern Trust
Wells Fargo & Company
Resona Asset Management
First Trust Advisors
Invesco
Riverbrige Partners

View all funds holding Exponent